» Articles » PMID: 38494537

The Fluorochrome-to-protein Ratio is Crucial for the Flow Cytometric Detection of Tissue Factor on Extracellular Vesicles

Overview
Journal Sci Rep
Specialty Science
Date 2024 Mar 18
PMID 38494537
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) have crucial roles in hemostasis and coagulation. They sustain coagulation by exposing phosphatidylserine and initiate clotting by surface expression of tissue factor (TF) under inflammatory conditions. As their relevance as biomarkers of coagulopathy is increasingly recognized, there is a need for the sensitive and reliable detection of TF EVs, but their flow cytometric analysis is challenging and has yielded controversial findings for TF expression on EVs in the vascular system. We investigated the effect of different fluorochrome-to-protein (F/P) ratios of anti-TF-fluorochrome conjugates on the flow cytometric detection of TF EVs from activated monocytes, mesenchymal stem cells (MSCs), and in COVID-19 plasma. Using a FITC-labeled anti-TF antibody (clone VD8), we show that the percentage of TF EVs declined with decreasing F/P ratios. TF was detected on 7.6%, 5.4%, and 1.1% of all EVs derived from activated monocytes at F/P ratios of 7.7:1, 6.6:1, and 5.2:1. A similar decline was observed for EVs from MSCs and for EVs in plasma, whereas the detection of TF on cells remained unaffected by different F/P ratios. We provide clear evidence that next to the antibody clone, the F/P ratio affects the flow cytometric detection of TF EVs and should be carefully controlled.

Citing Articles

Flow virometry: recent advancements, best practices, and future frontiers.

Fernandes C, Persaud A, Chaphekhar D, Burnie J, Belanger C, Tang V J Virol. 2025; 99(2):e0171724.

PMID: 39868829 PMC: 11853038. DOI: 10.1128/jvi.01717-24.


Quantitative fluorescent nanoparticle tracking analysis and nano-flow cytometry enable advanced characterization of single extracellular vesicles.

Mladenovic D, Brealey J, Peacock B, Koort K, Zarovni N J Extracell Biol. 2025; 4(1):e70031.

PMID: 39790179 PMC: 11707551. DOI: 10.1002/jex2.70031.

References
1.
Coly P, Boulanger C . Role of extracellular vesicles in atherosclerosis: An update. J Leukoc Biol. 2021; 111(1):51-62. DOI: 10.1002/JLB.3MIR0221-099R. View

2.
Puhm F, Flamand L, Boilard E . Platelet extracellular vesicles in COVID-19: Potential markers and makers. J Leukoc Biol. 2021; 111(1):63-74. PMC: 8667644. DOI: 10.1002/JLB.3MIR0221-100R. View

3.
Schiavello M, Vizio B, Bosco O, Pivetta E, Mariano F, Montrucchio G . Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation. Int J Mol Sci. 2023; 24(3). PMC: 9916541. DOI: 10.3390/ijms24031920. View

4.
Heemskerk J, Bevers E, Lindhout T . Platelet activation and blood coagulation. Thromb Haemost. 2002; 88(2):186-93. View

5.
Reddy E, Rand M . Procoagulant Phosphatidylserine-Exposing Platelets and . Front Cardiovasc Med. 2020; 7:15. PMC: 7062866. DOI: 10.3389/fcvm.2020.00015. View